Skip to main content
. 2022 Jan 19;98:106233. doi: 10.1016/j.ijsu.2022.106233

Table 2.

Polyclonal and Monoclonal antibodies.

Polyclonal (pAb) Monoclonal (mAb)
Low cost Expensive
Short (3–4 months) Time-consuming (up to a year)
Require considerable skills and training
Has high stability Has moderate stability
Moderate specificity High specificity
Has variable sensitivity Has moderate to high sensitivity
Very easy to be obtained. Difficult to be obtained.
Other drawbacks
1. Weak tissue penetration
2. Slow kinetics